Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole.
Buffered cephalothin, cefamandole, and cephapirin were compared with respect to their tendency to produce phlebitis. Two grams of each agent was administered every 6 h for 4 days to 12 healthy volunteers in a double-blind crossover fashion. Approximately 50% of intravenous sites developed mild (grade 1) phlebitis and 25% developed moderate (grade 2) phlebitis. The frequency of grade 1 inflammation did not differ significantly among the three cephalosporins. The proportion of individuals eventually exhibiting grade 2 phelebitis was highest with cefamandole, lowest with cephalothin (P = 0.07), and intermediate with cephapirin; however, cephapirin required a substantially greater number of doses to produce grade 2 phelebitis than did the other two drugs. These findings, together with the results of other reports, suggest that interpretation of the phlebitogenic potential of these antibiotics must be made with caution.
D000293:Adolescent; D000328:Adult; D002021:Buffers; D002511:Cephalosporins / Q000009:adverse effects*; D002512:Cephalothin / Q000009:adverse effects*; D002514:Cephapirin / Q000009:adverse effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008333:Mandelic Acids / Q000009:adverse effects; D010689:Phlebitis / Q000139:chemically induced*
D002021:Buffers; D002511:Cephalosporins; D008333:Mandelic Acids; D002514:Cephapirin; D002512:Cephalothin